Respiratory Devices Market Size to Reach USD 49.90 Billion by 2033 | ResMed Leads with 22.4% Market Share | North America Dominates with 39.7% Share

The global Respiratory Devices market reached USD 25.51 billion in 2025 and is projected to reach USD 49.90 billion by 2033, expanding at a CAGR of 8.8% during the forecast period from 2026 to 2033. The market has emerged as a strategic investment opportunity within the medical devices sector, driven by the rising prevalence of chronic respiratory diseases, increasing aging population, growing demand for home healthcare, and continuous advancements in respiratory care technologies. Investors are increasingly focusing on companies developing ventilators, oxygen concentrators, CPAP and BiPAP devices, nebulizers, inhalers, and advanced respiratory monitoring systems that improve patient outcomes and support long-term disease management. Growing investments in connected healthcare, portable medical devices, and digital respiratory solutions are strengthening the market's long-term growth potential.

Investment momentum continues to accelerate as medical device manufacturers, healthcare providers, and digital health companies expand their respiratory care portfolios through product innovation, strategic partnerships, and technological advancements. Developments in AI-powered respiratory monitoring, wearable respiratory sensors, portable oxygen therapy systems, smart inhalers, and remote patient monitoring platforms are improving treatment efficiency, patient compliance, and clinical decision-making. Rising demand for respiratory devices across hospitals, ambulatory care centers, home healthcare, and emergency care settings is creating significant commercial opportunities worldwide. As healthcare systems continue to prioritize early diagnosis, chronic disease management, and accessible respiratory care, the respiratory devices market is expected to remain a strategic investment segment supporting the future of connected and patient-centric healthcare.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/respiratory-devices-market?sai-v

Key Developments

June 2026: Philips expanded its respiratory devices portfolio by introducing AI-enabled connected respiratory care solutions with advanced remote monitoring capabilities, supporting the management of chronic respiratory diseases such as COPD, asthma, and sleep apnea through continuous patient monitoring and personalized therapy.

May 2026: ResMed strengthened its digital respiratory care ecosystem by enhancing cloud-connected CPAP, BiPAP, and ventilation devices with AI-driven analytics, enabling real-time therapy optimization, remote patient management, and improved treatment adherence.

April 2026: Fisher & Paykel Healthcare advanced its respiratory therapy portfolio by expanding next-generation humidification systems and non-invasive ventilation technologies designed to improve patient comfort, respiratory support, and clinical outcomes in hospital and homecare settings.

March 2026: Medtronic enhanced its respiratory intervention portfolio by introducing advanced ventilators and intelligent respiratory monitoring solutions integrated with digital health platforms, enabling improved respiratory care and optimized clinical decision-making.

February 2026: Dräger expanded its critical care respiratory device portfolio by advancing high-performance ventilators and respiratory monitoring systems with enhanced connectivity, predictive analytics, and integrated patient management capabilities for intensive care units and emergency medicine.

Key Players
ResMed | Koninklijke Philips N.V. | Medtronic plc | Fisher & Paykel Healthcare | GE HealthCare | Others

Key Highlights
ResMed - Holds a 22.4% share, driven by its leadership in sleep apnea and respiratory care devices, cloud-connected CPAP systems, digital health platforms, and extensive global distribution network.

Koninklijke Philips N.V. - Holds a 19.1% share, supported by its comprehensive respiratory care portfolio, ventilators, oxygen therapy systems, hospital respiratory solutions, and strong presence in home healthcare.

Medtronic plc - Holds a 16.3% share, strengthened by its advanced mechanical ventilators, airway management devices, respiratory monitoring systems, and broad critical care product portfolio.

Fisher & Paykel Healthcare - Holds a 13.7% share, fueled by its expertise in humidification systems, non-invasive ventilation technologies, high-flow oxygen therapy devices, and neonatal respiratory care solutions.

GE HealthCare - Holds a 11.2% share, driven by its intensive care ventilators, anesthesia delivery systems, respiratory monitoring technologies, and integrated critical care solutions.

Others - Hold a combined 17.3% share, comprising Drägerwerk, Getinge, Masimo, Baxter, Invacare, CorVent Medical, AstraZeneca, and other manufacturers providing ventilators, oxygen concentrators, nebulizers, respiratory monitoring devices, airway management systems, and home respiratory care solutions.

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=respiratory-devices-market?sai-v

Market Drivers
Increasing prevalence of chronic respiratory diseases, rising aging population, growing air pollution, and expanding demand for home healthcare are driving the growth of the respiratory devices market.

Growing adoption of ventilators, oxygen concentrators, CPAP and BiPAP devices, nebulizers, inhalers, and respiratory monitoring systems across hospitals, home care, and emergency settings is accelerating market expansion.

Continuous advancements in artificial intelligence (AI), IoT-enabled respiratory monitoring, portable oxygen delivery systems, smart inhalers, and non-invasive ventilation technologies are improving treatment outcomes, patient compliance, and clinical efficiency.

Rising healthcare expenditure, increasing awareness of respiratory health, expanding healthcare infrastructure, and supportive government initiatives for chronic disease management are supporting long-term market growth.

Market Opportunities
Growing demand for home respiratory care, remote patient monitoring, portable respiratory devices, and AI-powered respiratory management solutions is creating significant growth opportunities.

Increasing investments in connected healthcare, wearable respiratory monitoring devices, digital therapeutics, telehealth platforms, and advanced respiratory care technologies are expanding revenue potential across global markets.

Continuous advancements in smart inhalers, portable ventilators, cloud-based respiratory monitoring, predictive analytics, and next-generation oxygen therapy systems are opening new avenues for innovation.

Strategic collaborations among medical device manufacturers, healthcare providers, pharmaceutical companies, research institutions, and digital health companies are accelerating product development and global market expansion.

Industry Developments
Rapid advancements in portable ventilators, oxygen concentrators, CPAP and BiPAP systems, AI-enabled respiratory monitoring, and smart inhaler technologies are transforming the respiratory devices industry.

Increasing integration of AI, IoT, cloud computing, real-time patient monitoring, electronic health records (EHR), and predictive analytics is improving respiratory disease management, patient outcomes, and operational efficiency.

Strategic partnerships, mergers, acquisitions, product launches, regulatory approvals, and expansion of respiratory care portfolios are strengthening global market competitiveness.

Continuous investments in R&D, next-generation respiratory devices, wearable monitoring technologies, connected healthcare solutions, and personalized respiratory therapies are supporting long-term market expansion.

Regional Insights
North America 39.7% share: Leads the market with a 39.7% share due to advanced healthcare infrastructure, high prevalence of respiratory diseases, strong reimbursement policies, widespread adoption of advanced respiratory devices, and the presence of leading medical device manufacturers.

Europe 28.5% share: Growth is supported by a 28.5% market share, driven by increasing aging population, expanding home healthcare services, favorable healthcare policies, and growing demand for advanced respiratory care technologies.

Asia Pacific 24.3% share: Fastest-growing region with a 24.3% share, driven by rising air pollution, increasing prevalence of respiratory disorders, expanding healthcare infrastructure, and growing investments across China, India, Japan, and South Korea.

Latin America 4.2% share: Holds a 4.2% share, supported by improving healthcare access, increasing awareness of respiratory diseases, expanding healthcare investments, and growing adoption of respiratory care devices.

Middle East & Africa 3.3% share: Accounts for a 3.3% share, driven by expanding healthcare infrastructure, rising prevalence of chronic respiratory diseases, increasing government healthcare investments, and growing demand for advanced respiratory care solutions.

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/respiratory-devices-market?sai-v

Key Segments
➥ By Product Type

Therapeutic Devices: Represents the dominant segment, driven by the rising prevalence of chronic respiratory diseases and increasing demand for oxygen therapy, ventilators, and positive airway pressure devices.

Monitoring Devices: Represents a significant segment, supported by growing adoption of pulse oximeters, capnographs, and respiratory monitoring systems for continuous patient care.

Diagnostic Devices: Represents a substantial segment, fueled by increasing use of spirometers, peak flow meters, and pulmonary function testing equipment.

Consumables & Accessories: Represents a growing segment, driven by recurring demand for masks, tubing, filters, humidifiers, and breathing circuits.

Others: Represents a moderate segment, supported by expanding innovation in respiratory care technologies.

➥ By Application/Indication

Chronic Obstructive Pulmonary Disease (COPD): Represents the dominant segment, driven by the high global prevalence of COPD and long-term respiratory care requirements.

Asthma: Represents a significant segment, supported by increasing incidence of asthma and growing adoption of inhalation and monitoring devices.

Sleep Apnea: Represents the fastest-growing segment, fueled by rising diagnosis rates and increasing use of CPAP and BiPAP devices.

Pneumonia: Represents a substantial segment, driven by demand for oxygen therapy and ventilatory support in acute respiratory infections.

Cystic Fibrosis: Represents a growing segment, supported by increasing adoption of airway clearance and respiratory support devices.

Bronchitis: Represents a significant segment, fueled by the growing burden of chronic bronchitis and respiratory infections.

Others: Represents a moderate segment, driven by applications in pulmonary fibrosis, respiratory distress syndrome, and other respiratory disorders.

➥ By Portability

Stationary Devices: Represents the dominant segment, driven by widespread use in hospitals, intensive care units, and long-term respiratory care.

Portable Devices: Represents the fastest-growing segment, supported by increasing demand for home healthcare, ambulatory care, and lightweight respiratory support solutions.

➥ By End-User

Hospitals: Represents the dominant segment, driven by high patient admissions, critical care requirements, and advanced respiratory treatment infrastructure.

Homecare Settings: Represents the fastest-growing segment, fueled by increasing preference for home-based respiratory therapy, aging populations, and remote patient monitoring.

Ambulatory Surgical Centers (ASCs): Represents a significant segment, supported by growing outpatient surgical procedures requiring perioperative respiratory care.

Clinics: Represents a substantial segment, driven by increasing diagnosis and treatment of chronic respiratory disorders.

Emergency Medical Services (EMS)/Transport: Represents a growing segment, supported by rising demand for portable ventilators and emergency respiratory support systems.

Others: Represents a moderate segment, fueled by expanding adoption across rehabilitation centers, long-term care facilities, and specialty respiratory care centers.

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.